These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia. Goulielmos NV; Enayat ZE; Sheridan DJ; Cohen H; Flores NA Cardiovasc Res; 1995 Nov; 30(5):788-98. PubMed ID: 8595628 [TBL] [Abstract][Full Text] [Related]
3. Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia. Chakrabarty S; Thomas P; Sheridan DJ Eur Heart J; 1991 May; 12(5):583-9. PubMed ID: 1874258 [TBL] [Abstract][Full Text] [Related]
5. Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig. Flores NA; Sheridan DJ Br J Pharmacol; 1990 Nov; 101(3):734-8. PubMed ID: 2076489 [TBL] [Abstract][Full Text] [Related]
6. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets. Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979 [TBL] [Abstract][Full Text] [Related]
7. The deleterious effects of myocardial catecholamines on cellular electrophysiology and arrhythmias during ischaemia and reperfusion. Penny WJ Eur Heart J; 1984 Dec; 5(12):960-73. PubMed ID: 6442888 [TBL] [Abstract][Full Text] [Related]
9. Arrhythmogenic and electrophysiological effects of alpha adrenoceptor stimulation during myocardial ischaemia and reperfusion. Culling W; Penny WJ; Cunliffe G; Flores NA; Sheridan DJ J Mol Cell Cardiol; 1987 Mar; 19(3):251-8. PubMed ID: 3037089 [TBL] [Abstract][Full Text] [Related]
10. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets. Watts IS; Wharton KA; White BP; Lumley P Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of alpha-adrenoceptor stimulation in normal and ischemic myocardium. Sheridan DJ; Culling W J Cardiovasc Pharmacol; 1985; 7 Suppl 5():S55-60. PubMed ID: 2410737 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. Habib A; FitzGerald GA; Maclouf J J Biol Chem; 1999 Jan; 274(5):2645-51. PubMed ID: 9915793 [TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic and electrophysiological effects of alpha adrenoceptor blockade during myocardial ischaemia and reperfusion in isolated guinea-pig heart. Penny WJ; Culling W; Lewis MJ; Sheridan DJ J Mol Cell Cardiol; 1985 Apr; 17(4):399-409. PubMed ID: 2862287 [TBL] [Abstract][Full Text] [Related]
14. Effects of myocardial catecholamine depletion on cellular electrophysiology and arrhythmias during ischaemia and reperfusion. Culling W; Penny WJ; Lewis MJ; Middleton K; Sheridan DJ Cardiovasc Res; 1984 Nov; 18(11):675-82. PubMed ID: 6437681 [TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo. Ostermann G; Hofmann B; Kertscher HP; Till U Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302 [TBL] [Abstract][Full Text] [Related]
16. The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation. Wainwright CL; Parratt JR; Bigaud M Biomed Biochim Acta; 1988; 47(10-11):S224-7. PubMed ID: 3248108 [TBL] [Abstract][Full Text] [Related]
17. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. Piper PJ; Stewart AG Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369 [TBL] [Abstract][Full Text] [Related]
18. Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts. Koltai M; Tosaki A; Hosford D; Esanu A; Braquet P Cardiovasc Res; 1991 May; 25(5):391-7. PubMed ID: 1855244 [TBL] [Abstract][Full Text] [Related]
19. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. Adnot S; Joseph D; Vargaftig BB Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070 [TBL] [Abstract][Full Text] [Related]
20. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Lumley P; White BP; Humphrey PP Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]